T1CH34.SA Bio-Techne Corporation

Healthcare Biotechnology Sao Paulo Exchange
13.30 BRL
Close of Nov 5, 2026
7.33 13.30
Market cap
BRL 62.7B
P/E
66.5x
P/B
5.45x
ROE
8.6%
Dividend yield
0.29%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Jun 2026.

Is T1CH34.SA undervalued?

Graham number

The Graham number of Bio-Techne Corporation cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Bio-Techne Corporation fundamental analysis

No fundamental analysis for Bio-Techne Corporation yet.

Bio-Techne Corporation stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Bio-Techne Corporation

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. It operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines …

Full company profile